{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:59:36Z","timestamp":1747173576590,"version":"3.40.5"},"reference-count":10,"publisher":"Cambridge University Press (CUP)","issue":"10","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report the successful use of levosimendan in the treatment of heart failure in a patient with the univentricular heart. The presented case was atypical because our patient had systemic right ventricle. To our knowledge, it is the first reported such case with intermittent levosimendan administration as an effective treatment and bridge to successful heart transplant in a patient with functionally univentricular heart.<\/jats:p>","DOI":"10.1017\/s104795112000219x","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T08:16:27Z","timestamp":1595492187000},"page":"1504-1506","source":"Crossref","is-referenced-by-count":0,"title":["Levosimendan as a bridge to heart transplant in a 16-year-old patient with univentricular heart"],"prefix":"10.1017","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2148-3924","authenticated-orcid":false,"given":"Magdalena","family":"Mazurak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Cze\u015bniewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Kusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"S104795112000219X_ref10","first-page":"2129","article-title":"Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","year":"2016","journal-title":"EHJ"},{"key":"S104795112000219X_ref6","first-page":"147","article-title":"Levosimendan in single ventricle heart failure after longterm survival of a modified blalock-taussig shunt","volume":"26","author":"Tavares","year":"2019","journal-title":"Rev Port Cir Cardiotorac Vasc"},{"key":"S104795112000219X_ref9","first-page":"585","article-title":"Effects of levosimendan on right ventricular function in patients with acute decompensated heart failure","volume":"35","author":"Wang","year":"2019","journal-title":"Acta Cardiol Sin"},{"key":"S104795112000219X_ref3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/FJC.0b013e31826b86aa","article-title":"Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival","volume":"60","author":"Malfatto","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"S104795112000219X_ref4","doi-asserted-by":"crossref","first-page":"I11","DOI":"10.1093\/eurheartj\/suy040","article-title":"Repetitive levosimendan treatment in the management of advanced heart failure","volume":"20","author":"Oliva","year":"2018","journal-title":"Eur Heart J Suppl"},{"key":"S104795112000219X_ref1","doi-asserted-by":"crossref","first-page":"C8","DOI":"10.1093\/eurheartj\/sux004","article-title":"The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure","volume":"19","author":"Delgado","year":"2017","journal-title":"Eur Heart J"},{"key":"S104795112000219X_ref2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2015.08.188","article-title":"Repeated or intermittent levosimendan treatment in advanced heart failure: an updated meta-analysis","volume":"202","author":"Silvetti","year":"2016","journal-title":"Int J Cardiol"},{"key":"S104795112000219X_ref7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/icvts\/ivz319","volume":"30","author":"Iacobelli","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"S104795112000219X_ref8","doi-asserted-by":"crossref","first-page":"2045894018790905","DOI":"10.1177\/2045894018790905","article-title":"Levosimendan in pulmonary hypertension and right heart failure","volume":"8","author":"Hansen","year":"2018","journal-title":"Pulm Circ"},{"key":"S104795112000219X_ref5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S104795112000219X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T05:20:35Z","timestamp":1602739235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S104795112000219X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S104795112000219X"],"URL":"https:\/\/doi.org\/10.1017\/s104795112000219x","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"type":"print","value":"1047-9511"},{"type":"electronic","value":"1467-1107"}],"subject":[],"published":{"date-parts":[[2020,7,23]]}}}